{
  "url": "https://www.law.cornell.edu/regulations/new-york/14-NYCRR-816.5",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 14 ยง 816.5 - Standards applicable to all withdrawal and stabilization services",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 14 ยง 816.5 - Standards applicable to all withdrawal and stabilization services\n\nState Regulations\n(a) Services\napplicable to all levels of care. Medically supervised withdrawal services\nprovide assessment, medical supervision of intoxication and withdrawal\nconditions, pharmacological services, individual and group counseling, level of\ncare determination, and referral to other appropriate services. (b) Screening, linkages and\nreferral. (1)\n\nAll providers of\nwithdrawal and stabilization services must provide onsite medical, mental\nhealth and substance use disorder services as well as screening, linkages and\nreferral to other specialized providers of physical and behavioral health\nservices if such services cannot be provided by the withdrawal and\nstabilization program. (2)\n\nAll\nproviders must develop referral sources and keep updated lists of regional\nprograms which provide treatment and recovery services at all levels of\ncare. (3)\n\nAll providers must\nprovide screening and referral for specialized physical conditions and/or\nmental health conditions. (4)\n\nAll\nproviders shall provide overdose prevention education and naloxone education\nand training to a patient or prospective patient, and their significant\nother(s), in accordance with guidance issued by the Office. Providers shall\nmake a naloxone kit or prescription available to all patients or prospective\npatients and develop a safety plan with the patient as\nneeded. (c) Policies and procedures. The program governing authority must approve written policies, procedures and\nmethods governing the provision of services in compliance with Office\nregulations and guidance, including a description of each service provided. Such policies and procedures must include, at a minimum, the following: (1)\nprocedures and specific criteria for\nadmission, retention, level of care transition(s), referrals and\ndischarge; (2)\nlevel of care\ndeterminations utilizing a tool approved by OASAS to determine the appropriate\nlevel of care, treatment/recovery plans, and placement services; (3)\nstaffing for sufficient coverage and task\ndesignation; at least 50% of all clinical staff must be qualified health\nprofessionals as defined in Part 800 of this Title; (4)\nthe provision of medical services, including screening and referral for associated physical conditions; (5)\nthe provision of mental health services, including the use of OASAS approved, validated screening instruments for\nco-occurring mental health conditions and behavioral health risks, including\nsuicide risk, and referral for associated mental health conditions; (6)\nthe provision of evidence-based SUD\ntreatment services that are person-centered, strength-based and\ntrauma-informed; (7)\nprocedures for\nthe coordination of care with other service providers including transfers, emergency care and transport; (8)\na\nschedule of fees for services rendered; (9)\ninfection control procedures; (10)\ncooperative agreements with other SUD\ntreatment service providers or other providers of services that a patient may\nneed; (11)\ncompliance with other\nrequirements of applicable local, state, and federal laws and regulations, OASAS guidance documents and standards of care regarding, but not limited to: (i) education, counseling, prevention and\ntreatment of transmissible infections, including tuberculosis, viral hepatitis, sexually transmitted infections and HIV; regarding HIV, such education, counseling, prevention and treatment shall include condom use, testing, pre-\nand postexposure prophylaxis and treatment; (ii)\nthe use toxicology tests consistent with\nOASAS guidance; (iii)\nmedication\nand the use of medication for addiction treatment; (iv)\nmedication policies must ensure the\nappropriate continuation of medically appropriate and lawfully prescribed\nmedication(s) taken by the patient prior to admission; (12)\nrecord keeping procedures which ensure\nthat documentation is accurate, timely, prepared by appropriate staff, and in\nconformance with state and federal confidentially rules including 42 CFR Part\n2; (13)\nutilization review and\nquality improvement. All programs must have a utilization review process, a\nquality improvement process, and a written plan that identifies key performance\nmeasures; (14)\nmedical and nursing\nprocedures consistent with professional practice; (15)\npharmacological services including\nstorage and dispensing of medication pursuant to applicable state and federal\nregulations; (16)\nlaboratory testing\nprotocols, including alcohol screening and toxicology tests, such as breath\ntests and urine screening; (17)\ntoxicology policy; (18)\nincident\nreporting and review in accordance with this Title; and\n(19)\nscreening of patients and visitors and\nthe disposal of any items that create an unsafe environment; (i) programs must implement policies and\nprocedures to prevent and address the presence of items that create an unsafe\nenvironment in a manner that is trauma-informed, person-centered, respectful of\npatient and visitor dignity, and that reasonably balances the well-being and\nthe health and safety of all patients in the\nprogram. (d) Medical Protocols for Withdrawal Management. (1)\n\nProviders of withdrawal management and\nstabilization services must develop and implement written withdrawal management\nand stabilization protocols that are consistent with the following criteria, in\naccordance with guidance from the Office: (i) objective monitoring; (ii)\nsafety; (iii)\ninvolvement of\nmedical professionals; (iv)\nstabilization on medication for addiction treatment; (v) patient comfort; (vi)\nlevel of care assessment; and\n(vii)\ntransition to continued care. (2)\n\nProviders of withdrawal\nmanagement and stabilization services must obtain and maintain approval of\nmedical protocols for withdrawal management from the OASAS Chief Medical\n\nOfficer (CMO) or CMO designee by attesting that their protocols meet the\ncriteria identified herein and in guidance issued by the Office when seeking\nnew certification for, or continued operation of, withdrawal management and\nstabilization services. (i) Medical protocols\nare subject to review at any time by OASAS. (ii)\n\nMedical protocols not in compliance with\nthis Chapter and guidance issued by the Office and/or do not meet the standard\nof care for withdrawal management and stabilization services may result in\ncorrective and/or disciplinary action in accordance with this\n\nTitle. (e) Co-location. Substance use disorder withdrawal and\nstabilization services may be co located with other substance use disorder\nservices to ensure improved coordination of care and linkage. (f) Capacity. Capacity\napproved by the Office may not be exceeded at any time except with written\npermission from the Office. (g) Emergency medical kit. Each program shall maintain an emergency medical kit in accordance with the\nprovisions of Part 800 and applicable guidance. (h) Admission requirements for all\nprograms. (1)\n\nAdmission shall be\nbased upon a diagnosis of substance use disorder pursuant to the most recent\nedition of either the Diagnostic and Statistical Manual of the American\n\nPsychiatric Association, or the International Classification of\n\nDiseases. (2)\nA level of care\ndetermination must be made using the OASAS level of care assessment tool as\ndefined in Part 800 of this Title and documented in the patient\nrecord. (3)\n\nThe admission\nassessment or decision to admit must include identification of initial services\nneeded until the development of the treatment/recovery plan. (4)\n\nAn individual who presents to the\nwithdrawal and stabilization service seeking or having been referred for\ntreatment or assessment shall have an initial determination made and documented\nin a written record by a qualified health professional, or other clinical staff\nunder the supervision of a qualified health professional, which states that: (i) the individual appears to be in need of\nwithdrawal and stabilization services; and\n(ii)\nthe individual appears to be free of\nserious transmissible infections that could be transmitted through ordinary\ncontact; and\n(iii)\nthe individual\nappears not to need acute hospital care, acute psychiatric care, or other\nintensive services which cannot be provided in conjunction with withdrawal and\nstabilization services or which would prevent them from participating in\nsubstance use disorder treatment. (5)\n\nEach person admitted to the withdrawal\nand stabilization service must receive a medical evaluation as soon as\npossible, but no later than the first twenty-four (24) hours. (6)\n\nDecision to admit, notice to patient. (i) If determined appropriate for withdrawal\nand stabilization services, the patient shall be admitted, consistent with Part\n815 of this Title. (ii)\n\nThe\ndecision to admit a patient must be made by a clinical staff member who is a\nqualified health professional and must be documented by the dated signature\n(physical or electronic) of the qualified health professional working within\ntheir scope of practice and include the basis for admitting the\npatient; (iii)\nthere must be a\nnotation in the patient record that the patient received a copy of the\nwithdrawal and stabilization service's rules and regulations, including\npatient's rights, a summary of federal confidentiality requirements, and a\nstatement that such rules were discussed with the patient and the patient\nindicated that they understood them; (iv)\nall patients shall be informed that\nadmission is voluntary and that a patient shall be free to discharge themselves\nfrom the service at any time, provided however, this provision shall not\npreclude or prohibit attempts to persuade a patient to remain in the service in\ntheir own best interest. (a) For prospective\nor admitted patients under an external mandate, the potential consequences for\npremature discharge must be explained, including that the external mandate does\nnot alter the voluntary nature of admission, continued treatment, and\ntoxicology screening. (b) Any\npatient who desires to leave the service should be offered a physical\nexamination as soon as possible by medical personnel of the service. (7)\n\nIf the medical\npersonnel determine upon examination that such patient does not pose a danger\nto themselves or other persons because they are not incapacitated by a\nsubstance(s) to a degree that they may endanger themselves or other persons, or\nthat there is no need for medical or psychiatric intervention, the patient and\ntheir family/significant other shall receive the following prior to leaving the\nprogram: (i) education about the medical\nconsequences of untreated substance(s) withdrawal. (ii)\ninstructions for obtaining emergency\nmedical care for substance(s) withdrawal, should such care be\nnecessary; (iii)\nprescriptions for\nall medications, including medications for addiction treatments for substance\nuse disorder(s); (iv)\nreferrals to\nensure ongoing access to medications, including medication for addiction\ntreatment for substance use disorder(s); and\n(v) overdose prevention education, naloxone\neducation and training, and a naloxone kit or prescription regardless of\nsubstance use disorder diagnosis. (a) the\npatient record must document that the patient, and their family/significant\nother(s) were provided education about the medical consequences of untreated\nsubstance(s) withdrawal, instructions for obtaining emergency medical care for\nsubstance(s) withdrawal, prescriptions and/or other arrangements to ensure\naccess to medications, including medication for addiction treatment for\nsubstance use disorder(s), and overdose prevention education, naloxone\neducation and training, and a naloxone kit or prescription consistent with this\n\nPart. (b) The patient record must\ndocument the reasons why education about the medical consequences of untreated\nsubstance(s) withdrawal, instructions for obtaining emergency medical care for\nsubstance(s) withdrawal, prescriptions and/or other arrangements to ensure\naccess to medications, including medication for addiction treatment for\nsubstance use disorder(s), and overdose prevention education, naloxone\neducation and training, and a naloxone kit or prescription were not offered, if\nthe program is unable to provide these services or if the patient declines\nthese services. (8)\n\nIf an individual does not meet admission\ncriteria for the withdrawal and stabilization service, a referral to a service\nthat can meet the individual's treatment needs must be made, unless the\nindividual is already receiving substance use disorder services from another\nprovider. Individuals who do not meet admission criteria shall be informed of\nthe reason. (9)\n\nThe admission\nassessment or decision to admit shall contain a statement documenting the\nindividual is appropriate for this level of care, identify the assignment of a\nnamed clinical staff member with the responsibility to provide orientation to\nthe individual, and include a preliminary schedule of activities, therapies and\ninterventions. (i) Initial assessment. (1)\n\nExcept as otherwise provided in\nparagraph (2) of this subdivision, an initial assessment must be conducted by a\nclinical staff member. (2)\n\nThe\ninitial assessment must be completed within twenty-four (24) hours of admission\nand shall include whatever relevant information is necessary to develop an\nindividualized, person-centered, interdisciplinary treatment/recovery plan. The\ninitial assessment shall comprise of a written report of findings and\nconclusions and shall include the names of any staff or other persons\nparticipating in the assessment. (3)\n\nThe initial assessment shall include: (i) the patient's identifying and emergency\ncontact information; and\n(ii)\nthe\npatient's history and recent use of substances, substance use disorder\ntreatment history, medical history, psychiatric history, high risk behaviors, mental status, living arrangements, level of self-sufficiency, supports, and\nbarriers to treatment services; and\n(iii)\nany information concerning a medical or\npsychological condition that may affect communication or other functioning; and\n(iv)\ntransmissible infection\nrisk assessment (HIV, tuberculosis, viral hepatitis, sexual transmitted\ninfections, and other transmissible infections). (4)\n\nIf the patient had previously been\nadmitted to the same service within thirty (30) days of the current admission, the previous assessment may be utilized, provided that such documentation has\nbeen reviewed and determined to be current and accurate. (5)\n\nExcept for patients admitted to a\nmedically supervised outpatient service, no patient may be continued in the\nwithdrawal and stabilization service longer than seven (7) days after admission\nunless there is a reasonable probability that discharge criteria will be met\nwithin an additional seven (7) days. Current evidence must document a level of\ninstability requiring continued stay for adjustment of medication or attainment\nof a level of stability to enable functioning outside a structured setting; and\none of the following: (i) there is medical\nevidence of moderate to severe organ damage related to substance use; or\n(ii)\nthe patient is pregnant and\ncontinued stay is necessary to ensure stabilization and/or complete referral to\ncontinuing treatment; or\n(iii)\nthere\nis evidence of other medical complications warranting continued care in a\nwithdrawal and stabilization service. (6)\n\nMedical History and Physical\n\nExamination. (i) A medical history\nshall be taken, and a physical examination performed by a physician, physician\nassistant, or nurse practitioner within twenty-four (24) hours of admission. The physical examination will include but shall not be limited to the\ninvestigation of, and if appropriate, screenings for transmissible infections; pulmonary, cardiac or liver abnormalities; and physical and/or psychological\nconditions or limitations which may require special services or attention\nduring treatment. The physical examination shall also include the following\nlaboratory tests: (a) complete blood count\nand differential; (b) routine and\nmicroscopic urinalysis, as clinically indicated, and in accordance with\nguidance from the Office; (c) if\nmedically or clinically indicated, urine toxicology test; (d) blood-based tuberculosis test; (1)\nan intradermal PPD may be given in those\ncircumstances when a blood-based tuberculosis test cannot be performed; this\ntest is given and interpreted by the medical staff unless the patient is known\nto be PPD positive; (e) pregnancy test for persons of child-bearing potential; or\n(f) any other tests the examining physician, physician assistant, nurse practitioner or other medical staff member deems to\nbe necessary, including, but not limited to, an ECG or a chest\nX-ray. (ii)\n\nIf a medical\nhistory has been taken and a physical examination has been performed within the\nlast twenty-four (24) hours, the existing medical history and physical\nexamination documentation, including the results of laboratory and other\ndiagnostic tests, for the patient may be used to comply with the requirements\nof this Part, provided that such documentation has been reviewed and determined\nto be current and accurate. (a) A focused\nmedical history shall be taken and/or physical examination shall be performed\nand/or laboratory tests and other diagnostic tests shall be ordered if the\nexamining physician or other medical staff determine that elements of the\nexisting medical history and/or physical examination and/or the results of\nlaboratory and other diagnostic tests require reevaluation based on the\nclinical judgment of the examining physician or other medical staff. (b) A focused medical history and/or physical\nexamination shall be performed and/or laboratory, and other diagnostic tests\nshall be ordered if the patient has a physical complaint(s) that was not\naddressed in the existing medical history and /or physical examination, and/or\nthe patient has a new physical complaint(s) that has developed since the\nexisting medical history was taken and existing physical examination was\nperformed. (iii)\n\nPatient\nrecords shall include a summary of the results of the physical examination, laboratory test, and other diagnostic tests and shall also demonstrate that\nappropriate medical care, including psychiatric care, is recommended to any\npatient whose health status indicates the need for such\ncare. (j) Initial Services\n(1)\n\nThe initial assessment shall include an\nidentification of initial withdrawal and stabilization intervention services\nneeded, and schedules of individual and group counseling to address the needed\nservices until the development of the treatment/recovery plan. The initial\nservices shall be based on the withdrawal protocols that may be needed as well\nas the goals the patient identifies for treatment. (2)\n\nMedication for Addiction\n\nTreatment (MAT) for Substance Use Disorder (SUD)\n(i) The program shall maintain a patient with\nsubstance use disorder on approved medication, including those federal Food and\n\nDrug Administration (FDA) approved medications to treat substance use disorder, if deemed clinically appropriate and in collaboration with the patient's\nexisting provider, and with patient consent, in accordance with federal and\nstate rules and guidance issued by the Office. The program shall document such\ncontact with the existing program or practitioner prescribing such\nmedications. (ii)\n\nTo facilitate\naccess to full opioid agonist medication for patients who are maintained on\nsuch medication at the time of admission or who choose to start such medication\nduring admission, the program shall develop a formal agreement with at least\none Opioid Treatment Program (OTP) certified by the Office to facilitate\npatient access to full opioid agonist medication, if clinically appropriate. Such agreements shall address the program and the OTPs responsibilities to\nfacilitate patient access to such medication in accordance with guidance issued\nby the Office. (iii)\n\nThe program\nshall provide FDA approved medications to treat substance use disorder to an\nexisting patient or prospective patient seeking admission to an Office\ncertified program in accordance with all federal and state rules and guidance\nissued by the Office. (iv)\n\nThe\nprogram shall provide education to an existing patient or prospective patient\nwith substance use disorder about approved medications for the treatment of\nsubstance use disorder if the patient is not already taking such medications, including the benefits and risks.The program shall document such discussion and\nthe outcome of such discussion, including a patient's preference for or refusal\nof medication, in the patients record. (v) The program shall ensure that the\npatient's discharge plan includes an appointment with a treatment provider or\nprogram that can continue the medication post-discharge. (3)\n\nPsychosocial Treatment Requirements. (i) Group and individual psychosocial\ntreatment modalities must be offered. (ii)\n\nThese interventions must be\nevidenced-based, trauma-informed, personcentered, and individualized to the\nneeds of the patient per the clinical assessment, in accordance with guidance\nand standards from the Office. (k) Treatment/recovery plan. (1)\n\nEach patient must have a written person-centered\ntreatment/recovery plan developed by the clinical staff person with primary\nresponsibility for the patient, in collaboration with the patient and anyone\nidentified by the patient as supportive to recovery goals. The treatment plan\nbegins with the assessment incorporated into the patient record and is\nregularly updated with progress notes. The plan must be completed within\ntwenty-four (24) hours of admission and shall be based on the initial\nassessment conducted. The plan shall: (i) be\ndeveloped by the responsible clinical staff member(s), in collaboration with\nthe patient and anyone identified by the patient as supportive to recovery and\nsigned and dated by all parties when completed and agreed upon; (ii)\nprovide goals for the outcome of\ntreatment, the protocols to be followed for medical withdrawal and the clinical\ncare services to be provided; (iii)\nbe updated as appropriate and as required by the level of care should\nadditional problems requiring immediate treatment be identified; (iv)\nreflect coordination of medical, psychiatric, substance use care, and/or the provision of other services\nprovided concurrently either directly or through a secondary\nprovider; (v) be incorporated in\nthe patient's case record along with written orders, prescriptions and the\nprovision of withdrawal and stabilization services; and\n(vi)\ninclude provisions for prenatal care for\nall patients who are pregnant. If a pregnant patient refuses or does not obtain\nsuch care, the provider must have the patient acknowledge in writing that\nprenatal care was offered, recommended, and refused. The program should also\noffer to develop a plan of safe care with the patient and anyone identified by\nthe patient and such offer should be noted in the patient\nrecord. (2)\n\nContinuing review of treatment/recovery plan. The clinical\nstaff shall ensure that all treatment is provided in accordance with the\nindividual treatment/recovery plan. The treatment/recovery plan must be\nreviewed through the ongoing assessment process and regular progress notes. Revisions to the treatment/recovery plan shall be reflected in the patient's\nprogress notes, signed and dated by the responsible clinical staff. (3)\n\nProgress Notes. Progress notes are\nintended to document the patient's clinical status. Such progress notes shall\nprovide a chronology of all significant withdrawal, stabilization and SUD\nservices delivered to the patient, their progress related to the initial\nservices or the goals established in the treatment/recovery plan and be\nsufficient to delineate the course and results of treatments/services. Service\ndelivery should be documented in the patient record through regular progress\nnotes that include, unless otherwise indicated, the type, content, duration, and outcome of each treatment/service delivered to or on behalf of a patient, described and verified as follows: (i) be\nwritten, signed (physically or electronically) and dated by the clinical staff\nmember or another clinical staff member familiar with the patient's\ncare. (ii)\nrecord the relationship\nto the patient to the patient's developing treatment goals described in the\ntreatment/recovery plan; and\n(ii)\ninclude, as appropriate and relevant, any recommendations, communications, or\ndeterminations for initial, continued, or revised patient goals and/or\ntreatment; and\n(iv)\ninclude all\nindividual, medical, and psychiatric contacts for the purpose of assessing, diagnosing, or treating the patient. (v) Unless additional requirements apply to\nspecific levels of withdrawal and stabilization services, progress notes shall\nbe documented no less often than once per shift for the first five (5) days and\nno less often than once per day thereafter. (vi)\n\nIf a patient's condition necessitates\nmore frequent documentation, the appropriate staff must document the provision\nof those services and/or care in the patient's progress notes. (vii)\n\nThe program's multidisciplinary team, as defined in Part 800 of this Title, shall meet on a regularly scheduled basis\nfor the purpose of reviewing a sample of cases for the purpose of clinical\nmonitoring of practice. This meeting shall be documented as to date, attendance, cases reviewed and recommendations. (l) Discharge and planning for level\nof care transitions. (1)\n\nDischarge\nand planning for level of care transition shall commence upon admission and\nshall be considered part of the treatment/recovery planning process. The plan\nfor discharge or level of care transition shall be developed by the clinical\nstaff member(s) with primary responsibility for the patient in collaboration\nwith the patient and anyone identified by the patient as supportive to\nrecovery. Planning must provide a framework for a long-term, patient-driven\ntreatment/recovery plan and link the patient to appropriate level of care\ntransition services to support the plan; and include detailed information on\nreferral and plan specifics. No patient shall be discharged until the plan is\ncomplete and identifies a staff member assigned to follow up on referrals. Documentation detailing why a discharge or level of care transition plan was\nnot provided to the patient must be placed in the medical record, if the\npatient did not receive a plan. (2)\n\nDischarge and/or level of care transitions should occur when: (i) the patient meets criteria documented by\nthe OASAS level of care determination protocol for an alternate level of care\nand has been medically withdrawn from a substance(s) they are physiologically\ndependent on, has been stabilized on a medication(s) for addiction treatment if\nsuch treatment(s) were initiated during admission, has co-occurring medical\nand/or psychiatric symptoms that have been stabilized, and has developed a\ndischarge or level of care transition plan; (ii)\nthe patient and the medical and clinical\nstaff agree that the patient has received maximum benefit from the withdrawal\nand stabilization services provided by the program; or\n(iii)\nthe patient does not adhere to the\nprogram's written behavioral standards, provided that the patient is offered a\nreferral and connection to another treatment program. (a) discharge for behavioral reasons with a\nreferral and connection to another treatment program shall only occur after the\nprogram has utilized behavioral interventions to help the patient manage their\nbehavior in a less disruptive manner and discharge must be consistent with the\nprovisions of Part 815 of this Title. (3)\n\nThe plan shall include, but not be\nlimited to at least the following: (i) an\nevaluation of the patient's living arrangement, level of self-sufficiency and\navailable support systems; (ii)\nidentification of substance use disorder treatment and other services the\npatient will need after discharge including alternative medical and mental\nhealth providers; and\n(iii)\na list\nof current medications. (a) A member of the\nclinical and medical staff who participated in preparing the plan, and the\npatient, shall sign and date the plan upon its completion. Except for medically\nmonitored withdrawal and stabilization services, the program physician shall\nalso sign and date the plan. (b) The plan shall be discussed with the patient, given to the patient upon\ndischarge and with appropriate patient consent, the plan, including level of\ncare transition planning, shall be forwarded to any subsequent service\nproviders. The patient and their family/significant other(s) shall be offered\noverdose prevention education, naloxone education and training, and a naloxone\nkit or prescription. (c) For a\npatient transitioning directly from a withdrawal and stabilization service to\nanother service within the same facility, a transfer plan may take the place of\na discharge plan. To ensure sufficient information is available to the new\nservice, a transfer plan must include information about the patient's immediate\nneeds, medical and psychiatric diagnoses, medications and plan for meeting\nthose needs. (m) Patient records. (1)\n\nProviders must keep individual patient\nrecords for each patient admitted. These records must include, at a minimum, all information and documentation required in this Part, including but not\nlimited to: (i) identifying information about\nthe patient and their family; (ii)\nthe source of referral, date of commencing service, and names of clinical staff\nwho have primary responsibility for the patient's care; (iii)\na notation that the patient received a\ncopy of the program's rules and regulations, including patient's rights\nconsistent with Part 815 of this Title and a summary of the federal\nconfidentially requirements, that such rules and regulations were discussed\nwith the patient, including their ability to designate individuals to be\nnotified in case of an emergency, and that the patient indicated they\nunderstood them; (iv)\nthe admission\ndiagnosis, including substance-related, medical, and psychiatric diagnoses in\nofficial nomenclature with associated diagnostic codes in the most recent\nversion of the Diagnostic and Statistical Manual (DSM) or the International\n\nClassification of Diseases (ICD); (v) any clinical and non-clinical\ndocumentation or determination applicable to the delivery of withdrawal and\nstabilization treatment services for a patient and/or supporting the patient's\nevolving recovery treatment/recovery plan; (vi)\nthe individual treatment/recovery plan\nand all reviews and updates thereto through progress notes; (vii)\nreports of all assessments performed, including findings and conclusions; (viii)\nreports of all examinations performed, including but not limited to X-rays and/or other imaging studies, clinical\nlaboratory tests, clinical psychological tests, electroencephalograms, and\npsychometric tests\n(ix)\ndocumentation of public health education and screening with regard to\ntuberculosis, sexually transmitted infections, hepatitis, and HIV prevention\nand harm reduction. (x) summaries\nof case conferences, and special consultations held. (xi)\ndated and signed prescriptions or orders\nfor all medications with notation of termination dates; (xii)\ndocumentation that the patient, and\ntheir family/significant other(s), were offered overdose prevention education, naloxone education and training and a naloxone kit or prescription; (xiii)\ndocumentation should include, if\napplicable, the reasons why overdose prevention education, naloxone education\nand training, and/or a naloxone kit or prescription were not offered or the\nreasons why the patient declined overdose prevention, naloxone education and\ntraining and/or a naloxone kit or prescription. (xiv)\nthe discharge plan; (xv)\nany other documents or information\nregarding the patient's condition, treatment, and results of treatment; and\n(xvi)\nsigned forms consenting\nto treatment and for obtaining or releasing confidential information in\naccordance with 42 Code of Federal Regulations Part 2 or other applicable\nlaw. (2)\n\nPatient records\nshall be maintained, shared with other clinical staff involved in the treatment\nof a patient and with professional staff or other providers involved in the\ncare of such patient, and released in accordance with state and federal laws\nand regulations governing confidentiality. (n) Staffing. (1)\n\nStaff may be either specifically assigned to the\nwithdrawal and stabilization service or may be part of the staff of the\nfacility within which the service is located, provided that: (i) they have specific training in the\ndiagnosis and treatment of substance use disorder, including person-centered, trauma-informed principles; and\n(ii)\nthe service identifies and documents the percentage of time each shared staff\nmember is assigned to each service. (2)\nA withdrawal and stabilization service\nshall have regular, scheduled, and documented training made available in the\nfollowing subject areas, or as determined by the Office: (i) diagnosing substance use disorder and\nother addictive disorders; (ii)\nsigns and symptoms of withdrawal from all classes of substances; (iii)\ncomplications of withdrawal from all\nclasses of substances; (iv)\npublic\nhealth education and screening with regard to tuberculosis, sexually\ntransmitted infections, viral hepatitis, and HIV prevention and harm reduction, and, (v) certification in\ncardiopulmonary resuscitation from the American Red Cross, the American Heart\n\nAssociation or an equivalent nationally recognized organization within one year\nof hire, to be renewed as needed. (3)\n\nEach service shall have a qualified\nindividual designated as the Health Coordinator to ensure the provision of\neducation, risk reduction, counseling and referral services to all patients\nregarding HIV, tuberculosis, viral hepatitis, sexually transmitted infections, and other transmissible infections. (4)\n\nClinical staff shall have primary\nresponsibility for implementing the treatment/recovery plan. (5)\n\nMedical staff shall have primary\nresponsibility for coordinating medical care including, but not limited to, physical examination, prescription, dispensing, and/or administration of\nmedications, observation of symptoms, and vital signs and the provision of\nnursing care. (6)\n\nAdditional\nstaffing requirements specific to the type of withdrawal and stabilization\nservice provided pursuant to applicable sections of this\n\nPart. Notes\nN.Y. Comp. Codes\nR. & Regs. Tit. 14\nยง\n816.5\n\nAdopted\n\nNew\n\nYork State Register March 27, 2019/Volume XLI, Issue 13, eff. 3/27/2019\n\nAmended\n\nNew\n\nYork State Register September 14, 2022/Volume XLIV, Issue 37, eff. 10/1/2022\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 34903
}